Crossmark

A retrospective analysis of combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in patients with MASLD

Crossref DOI link: https://doi.org/10.1038/s41467-025-62891-8

Published Online: 2025-08-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Jheng-Yan https://orcid.org/0000-0002-3290-1909
Hsu, Wan-Hsuan

Kuo, Chia-Chih

Tsai, Ya-Wen

Liu, Ting-Hui

Huang, Po-Yu

Chuang, Min-Hsiang

Hung, Kuo-Chuan

Yu, Tsung

Lai, Chih-Cheng https://orcid.org/0000-0002-6334-2388
License Information

Text and Data Mining valid from 2025-08-12

Version of Record valid from 2025-08-12
More Information

Article History

Received: 25 November 2024

Accepted: 31 July 2025

First Online: 12 August 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below